Baoqiang Guo
Overview
Explore the profile of Baoqiang Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
595
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin J, Huang C, Zhao J, Li L, Wu Z, Zhang T, et al.
Front Pharmacol
. 2024 Oct;
15:1449178.
PMID: 39359254
The autophagy-lysosome pathway plays an essential role in promoting lipid catabolism and preventing hepatic steatosis in non-alcoholic fatty liver disease (NAFLD). Transcription factor EB (TFEB) enhances the autophagy-lysosome pathway by...
2.
Guo B, Xu X, Chi X, Wang M
Ir J Med Sci
. 2024 Jun;
193(5):2293-2299.
PMID: 38837012
Background: Diabetic peripheral neuropathy (DPN) frequently occurs as a secondary condition in individuals with type 2 diabetes mellitus (T2DM). Objective: To explore the relationship of lncRNA FTX and miR-186-5p levels...
3.
Jin D, Jin S, Zhou T, Cui Z, Guo B, Li G, et al.
Medicine (Baltimore)
. 2024 Mar;
103(10):e36907.
PMID: 38457538
Background: Prior research has demonstrated a positive association between the composition of gut microbiota and the incidence of pancreatic cancer. Nevertheless, a thorough quantitative and systematic evaluation of the distinct...
4.
Jin D, Jin S, Zhou T, Cui Z, Guo B, Li G, et al.
Front Public Health
. 2024 Jan;
11:1295165.
PMID: 38259755
Background And Aim: Europe faces an elevated risk of nonalcoholic fatty liver disease (NAFLD) among people living with HIV (PLWH), contributing to the region's highest global burden of NAFLD. However,...
5.
Zhou A, Jou E, Lu V, Zhang J, Chabra S, Abishek J, et al.
Tissue Eng Regen Med
. 2023 Aug;
20(6):793-809.
PMID: 37651091
Recent studies of exosomes derived from mesenchymal stem cells (MSCs) have indicated high potential clinical applications in many diseases. However, the limited source of MSCs impedes their clinical research and...
6.
Combes L, Sawkulycz X, Fang W, Guo B, Slevin M
Biophys Rep
. 2023 Jun;
7(2):81-90.
PMID: 37288148
Stem cell therapy is a promising treatment for neurogenerative disease as well as inflammatory and immune mediated diseases. Decades of preclinical research has demonstrated stem cell ability to differentiate into...
7.
Jin D, Cui Z, Jin S, Zhou T, Guo B, Gao P, et al.
Front Pharmacol
. 2023 Jan;
13:1096064.
PMID: 36699084
Design: The efficacy of various anti-diabetic medicines on non-alcoholic fatty liver disease in the absence of diabetes was evaluated by searching Pubmed, Embase, Cochrane Library, and Web of Science for...
8.
Zhang C, Wang J, Song X, Yu D, Guo B, Pang Y, et al.
Br J Cancer
. 2022 Dec;
128(5):766-782.
PMID: 36526675
Background: Deregulation of either RNA polymerase I (Pol I)-directed transcription or expression of signal transducer and activator of transcription 3 (STAT3) correlates closely with tumorigenesis. However, the connection between STAT3...
9.
Guo Z, Yang Y, Li L, Zhao Q, Li Y, Liu Z, et al.
Eur J Pharmacol
. 2022 Oct;
934:175307.
PMID: 36191632
Background & Aims: Hypoxia inducible factor (HIF) is a hypoxia-associated transcription factor that has a protective role against hypoxia-induced damage. Prolyl hydroxylase-2 (PHD2) is a dioxygenase enzyme that specifically hydroxylates...
10.
Wang J, Chen Q, Wang X, Zhao S, Deng H, Guo B, et al.
Hum Mol Genet
. 2022 Aug;
32(1):104-121.
PMID: 35925837
Eukaryotic RNA polymerase I (Pol I) products play fundamental roles in ribosomal assembly, protein synthesis, metabolism and cell growth. Abnormal expression of both Pol I transcription-related factors and Pol I...